Michael Wayne Graham
22Patents
8h-index
23Co-inventors
75Inventor score
Filing activity: Jun 19, 1998 → Jan 8, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6573099B2 | Genetic constructs for delaying or repressing the expression of a target gene | Chemistry; Metallurgy | 354 | Expired |
| US7754697B2 | Control of gene expression | Chemistry; Metallurgy | 33 | Expired |
| US8598332B1 | Methods and means for obtaining modified phenotypes | Chemistry; Metallurgy | 17 | Expired |
| US8168774B2 | Control of gene expression | Chemistry; Metallurgy | 16 | Active |
| US8053419B2 | Synthetic genes and genetic constructs | Chemistry; Metallurgy | 14 | Expired |
| US8048670B2 | Synthetic genes and genetic constructs | Chemistry; Metallurgy | 13 | Expired |
| US8067383B2 | Synthetic genes and genetic constructs comprising same I | Chemistry; Metallurgy | 12 | Active |
| US8431547B2 | Synthetic genes and genetic constructs | Chemistry; Metallurgy | 9 | Active |
| US9672631B2 | Medical image reporting system and method | Physics | 5 | Active |
| US9029527B2 | Synthetic genes and genetic constructs | Chemistry; Metallurgy | 2 | Active |
| US9518260B2 | Pain treatment | Chemistry; Metallurgy | 2 | Active |
| US9963698B2 | Control of gene expression | Chemistry; Metallurgy | 1 | Active |
| US10898505B2 | Reagents for treatment of hepatitis B virus (HBV) infection and use thereof | Chemistry; Metallurgy | 1 | Active |
| US9441239B2 | Methods and means for obtaining modified phenotypes | Human Necessities | 1 | Expired |
| US10482606B2 | Medical image reporting system and method | Physics | 1 | Active |
| US9790502B2 | HBV treatment | Chemistry; Metallurgy | 0 | Active |
| US11591005B2 | Tunable dynamic absorber for attenuating vibration | Mechanical Engineering; Lighting; Heating | 0 | Active |
| US7855071B2 | Synthetic genes and genetic constructs | General | 0 | Revoked |
| US10006048B2 | Synthetic genes and genetic constructs | Chemistry; Metallurgy | 0 | Active |
| US9080174B2 | HBV treatment | Chemistry; Metallurgy | 0 | Active |
| US11234994B2 | Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof | Chemistry; Metallurgy | 0 | Active |
| US9410154B2 | HBV treatment | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.